DarioHealth Corp
NASDAQ:DRIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
DarioHealth Corp (DRIO) under the Base Case is 10.1 USD per share.
Compared with the current market price of 1.44 USD, the stock appears
Undervalued by 86% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What DarioHealth Does
DarioHealth Corp makes digital tools that help people manage long-term health problems such as diabetes, high blood pressure, weight issues, and pain. Its main product is a connected app and device system that lets users track health data, get coaching, and follow care plans from their phones. The company sells these programs to employers, health plans, healthcare providers, and some individual users who want easier day-to-day disease management.
- Headquarters
- United States of America US
- Employees
- 163
- IPO date
- Mar 8, 2013
Balance Sheet
Recent Events
Latest Earnings Call
Management expects contracted-account conversion to drive revenue acceleration into 2027, as Dario positions its platform across consumer access and payer-funded care.
Open the earnings call- EPS
- −$0.73
- Expected
- −$0.68
- Surprise
- −7.4%
- Stock, day of the call
- −22.4%
DarioHealth insiders are buying within their usual range
Past 12 months
Continue DRIO Research
Decided on DarioHealth? Get an email when DRIO reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one DRIO stock?
The intrinsic value for
DarioHealth Corp (DRIO) under the Base Case is 10.1 USD.
Is DRIO stock undervalued or overvalued?
Compared with the current market price of 1.44 USD, the stock appears Undervalued by 86% .